Clinical Trial

Effects of DL-endopeptidase Producing Probiotics on Human Intestinal NOD2 Ligands and Related Functions

Study acronym: probiotics
Active, Not Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
We have discovered a type of probiotic that can target activating intestinal NOD2, which is related to a series of human health issues.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-28.
Status change: Recruiting → Active, Not Recruiting 2026-01-04
Trial Details
NCT Number NCT06716047
Lead Sponsor Zhujiang Hospital
Conditions Microecological Therapy, Probiotic Intervention
Enrollment 30 participants
Start Date 2024-12-05
Primary Completion 2025-06-25 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-07